Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Vaccines

  Free Subscription


03.11.2025

3 BMJ
1 Clin Infect Dis
1 Infect Immun
1 J Gen Virol
2 J Immunol
1 J Infect Dis
1 J Pediatr
2 JAMA
2 N Engl J Med
1 Nat Med
1 Pediatrics
1 PLoS Med
4 PLoS One
1 Proc Natl Acad Sci U S A
17 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. LOGAN M
    Doctors mount resistance to Florida plan to end vaccine mandates, despite gagging.
    BMJ. 2025;391:r2305.
    PubMed        

  2. LOOI MK
    Seth Berkley interview: vaccination in a time of extreme scepticism.
    BMJ. 2025;391:r2184.
    PubMed        

  3. WISE J
    mRNA covid vaccines may "turbo charge" cancer immunotherapy, research suggests.
    BMJ. 2025;391:r2245.
    PubMed        


    Clin Infect Dis

  4. FONG Y, Huang Y, Huang Y, Woo W, et al
    Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine.
    Clin Infect Dis. 2025 Oct 25:ciaf558. doi: 10.1093.
    PubMed         Abstract available


    Infect Immun

  5. LATRE DE LATE P, Stoll IM, Ferm J, Madesh S, et al
    Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.
    Infect Immun. 2025 Oct 29:e0041225. doi: 10.1128/iai.00412.
    PubMed         Abstract available


    J Gen Virol

  6. DVORAK M, Arbon D, Salat J, Fortova A, et al
    Erratum: Sex-dependent impairment of antibody responses to tick-borne encephalitis virus vaccination and infection in obese mice.
    J Gen Virol. 2025;106:002171.
    PubMed        


    J Immunol

  7. SILVA-MORAES V, Reis LR, Ross TM
    Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.
    J Immunol. 2025 Oct 30:vkaf286. doi: 10.1093.
    PubMed         Abstract available

  8. CABALEIRO S, Fandino B, Fernandez-Torrecillas P, Riera-Fernandez P, et al
    The recall of antigen-specific antibody-secreting cells in Solea senegalensis gives clues on the secondary immune response in flatfish.
    J Immunol. 2025;214:2648-2662.
    PubMed         Abstract available


    J Infect Dis

  9. CAO Y, Hayashi CTH, Tripathi AK, Takashima E, et al
    Pfs230 Domains 7-10 encoded by DNA vaccines induce potent complement-independent transmission-blocking antibody against Plasmodium falciparum.
    J Infect Dis. 2025 Oct 31:jiaf555. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr

  10. BRUGHA R, Kirkham A, Bate J, Burke GAA, et al
    SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.
    J Pediatr. 2025 Oct 23:114873. doi: 10.1016/j.jpeds.2025.114873.
    PubMed         Abstract available


    JAMA

  11. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    PubMed        

  12. PANT S
    First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks.
    JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17533.
    PubMed        


    N Engl J Med

  13. MCCANN N, Paganotti Vicentine M, Ebrahimi N, Greenland M, et al
    Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.
    N Engl J Med. 2025;393:1704-1714.
    PubMed         Abstract available

  14. SCOTT J, Abers MS, Marwah HK, McCann NC, et al
    Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
    N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMsa2514268.
    PubMed         Abstract available


    Nat Med

  15. NAIR NP, Reddy SN, Giri S, Varghese T, et al
    Author Correction: Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016-2020.
    Nat Med. 2025 Oct 27. doi: 10.1038/s41591-025-04062.
    PubMed        


    Pediatrics

  16. NAURECKAS LI C, Edwards KM, Kaplan SL, Marshall GS, et al
    What's Old Is New Again: Pertussis.
    Pediatrics. 2025;156:e2025072868.
    PubMed         Abstract available


    PLoS Med

  17. SHEN J, Kharitonova E, Tytula A, Zawieja J, et al
    Correction: Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.
    PLoS Med. 2025;22:e1004789.
    PubMed         Abstract available


    PLoS One

  18. NIROB MNH, Sultana I, Al Arian T, Islam MS, et al
    A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections.
    PLoS One. 2025;20:e0334885.
    PubMed         Abstract available

  19. EPAULARD O, Carre M, Hermet E, Corbin V, et al
    Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial.
    PLoS One. 2025;20:e0335224.
    PubMed         Abstract available


  20. Correction: Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2025;20:e0335673.
    PubMed         Abstract available

  21. KONOMI F, Bino S, Mersini K, Ramaj A, et al
    COVID-19 breakthrough infections during the circulation of Delta and Omicron variants in Tirana, Albania, April 2021-March 2022.
    PLoS One. 2025;20:e0335197.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. WAGNER AA, Herrera DP, Rudder AL, Kinsey C, et al
    Accessing robust vaccine coformulation stability by single adjuvant detection on a microelectrode.
    Proc Natl Acad Sci U S A. 2025;122:e2522044122.
    PubMed         Abstract available


    Vaccine

  23. TIAN J, Wang X, Gu L, Ren J, et al
    Optimizing immunization through concurrent vaccination: a safety and cost analysis of PCV13 and rotavirus vaccines co-administration in Shanghai.
    Vaccine. 2025;68:127880.
    PubMed         Abstract available

  24. SAUVAGEAU C, Ionescu IG, Ouakki M, Panicker G, et al
    Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination.
    Vaccine. 2025;68:127893.
    PubMed         Abstract available

  25. MIRANDA-HERNANDEZ S, Sathkumara HD, Zhao G, Schofield L, et al
    Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis.
    Vaccine. 2025;68:127912.
    PubMed         Abstract available

  26. GUO Z, Li J, Luo M, Shuai W, et al
    Development and immunogenicity of a recombinant PRRSV live vector co-expressing CSFV E2 antigen and porcine IL-18 for multivalent swine vaccination.
    Vaccine. 2025;68:127886.
    PubMed         Abstract available

  27. LI V, McClure H, Patel R, Kuchel GA, et al
    Medication count, including statin or metformin use, is not associated with influenza vaccine responses in older adults.
    Vaccine. 2025;68:127913.
    PubMed         Abstract available

  28. SHAO J, Yang B, Feng S, Zhi Q, et al
    Evaluating the impact of different MMR vaccination strategies on mumps incidence in Shapingba, China:An interrupted time series analysis.
    Vaccine. 2025;67:127885.
    PubMed         Abstract available

  29. ASTURIAS EJ, Chen LH, Shaw AC, Moser CA, et al
    Science for vaccine policy: Independent review of the September 2025 ACIP processes, deliberations and votes.
    Vaccine. 2025;67:127876.
    PubMed         Abstract available

  30. ACHARYA KP, Phuyal S, Lopes BS
    Overcoming vaccine cold chain challenges in Nepal's animal health sector: innovative strategies for effective immunisation.
    Vaccine. 2025;67:127857.
    PubMed        

  31. ABDUL AZIZ N, Kirsebom FCM, Allen A, Andrews N, et al
    Effectiveness of spring 2024 (XBB.1.5) and autumn 2024 (JN.1) COVID-19 vaccination against hospitalisation in England.
    Vaccine. 2025;67:127870.
    PubMed         Abstract available

  32. DONAHUE JG, Cocoros NM, Kieke BA, Hanson KE, et al
    Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalink.
    Vaccine. 2025;67:127873.
    PubMed         Abstract available

  33. LOURENCO KL, Oliveira Paim AA, Hojo-Souza NS, Queiroz-Junior CM, et al
    The LVD/NIAID/NIH MVA1974 clone as an Mpox vaccine - preclinical assessment upon in a model of lethal infection with Orthopoxvirus monkeypox in mice.
    Vaccine. 2025;67:127889.
    PubMed         Abstract available

  34. LIU X, Han S, Wang H, Sun L, et al
    Immunogenicity and safety of co-administration of sabin-strain-based inactivated poliovirus vaccine, diphtheria-tetanus-acellular pertussis vaccine, and live attenuated hepatitis A vaccine in 18-month-old children: A multicenter randomized controlled
    Vaccine. 2025;67:127891.
    PubMed         Abstract available

  35. NOROOZI A, Esha SM, Ghari M
    Predictors of childhood vaccination uptake in England: an explainable machine learning analysis of regional data (2021-2024).
    Vaccine. 2025;68:127902.
    PubMed         Abstract available

  36. GROMER DJ, Kalash S, Tanios R, Rouphael N, et al
    The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review.
    Vaccine. 2025;68:127892.
    PubMed         Abstract available

  37. LOPEZ-ZAMBRANO MA, Sanchez-Gomez A, Lasheras Carbajo MD, Gutierrez Rodriguez MA, et al
    Trend and factors associated to pertussis and influenza vaccination in pregnant women in Madrid, Spain, 2018-2023 - a retrospective cohort study.
    Vaccine. 2025;68:127895.
    PubMed         Abstract available

  38. ZENG S, Fu Z, Wang Y, Jiang S, et al
    Construction and evaluation of a chimeric vaccine against Clostridium perfringens type a of sika deer.
    Vaccine. 2025;68:127899.
    PubMed         Abstract available

  39. REINHOLM A, Khan H, Laakso T, Maljanen S, et al
    Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1.
    Vaccine. 2025;68:127894.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.